| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.836 | 0.002 | 0.917 | Nav1.1 sodium channel blocker | 0.32 0.007 DBMET00278 0.917 0.001 DBMET00056 0.399 0.005 DBMET00057 0.399 0.005 DBMET01808 | DBMET00056 | |
| 0.81 | 0.004 | 0.817 | Anticonvulsant | 0.817 0.004 DBMET00056 0.159 0.118 DBMET00057 0.159 0.118 DBMET01808 | DBMET00056 | |
| 0.566 | 0.002 | 0.566 | Liver X receptor agonist | 0.073 0.012 DBMET00278 0.389 0.003 DBMET00056 0.174 0.004 DBMET00057 0.174 0.004 DBMET01808 | ||
| 0.574 | 0.059 | 0.574 | Beta lactamase inhibitor | 0.224 0.17 DBMET00278 0.42 0.094 DBMET00056 0.193 0.19 DBMET00057 0.193 0.19 DBMET01808 | ||
| 0.379 | 0.008 | 0.577 | Tumour necrosis factor antagonist | 0.206 0.05 DBMET00278 0.577 0.003 DBMET00056 0.15 0.1 DBMET00057 0.15 0.1 DBMET01808 | DBMET00056 | |
| 0.398 | 0.062 | 0.462 | GABA C receptor rho-3 antagonist | 0.395 0.064 DBMET00278 0.371 0.075 DBMET00056 0.462 0.038 DBMET00057 0.462 0.038 DBMET01808 | DBMET01808 | |
| 0.34 | 0.039 | 0.52 | Superoxide dismutase inhibitor | 0.418 0.024 DBMET00278 0.52 0.011 DBMET00056 0.342 0.038 DBMET00057 0.342 0.038 DBMET01808 | DBMET00056 | |
| 0.353 | 0.059 | 0.571 | Immunomodulator | 0.338 0.064 DBMET00056 0.571 0.014 DBMET00057 0.571 0.014 DBMET01808 | DBMET01808 | |
| 0.297 | 0.02 | 0.297 | Neuropeptide Y2 antagonist | 0.255 0.051 DBMET00278 0.262 0.045 DBMET00056 0.275 0.034 DBMET00057 0.275 0.034 DBMET01808 | ||
| 0.35 | 0.077 | 0.405 | Thioredoxin glutathione reductase inhibitor | 0.358 0.073 DBMET00278 0.405 0.055 DBMET00056 0.304 0.1 DBMET00057 0.304 0.1 DBMET01808 | DBMET00056 | |
| 0.308 | 0.039 | 0.308 | Cyclic AMP phosphodiesterase inhibitor | 0.237 0.07 DBMET00056 0.197 0.096 DBMET00057 0.197 0.096 DBMET01808 | ||
| 0.295 | 0.034 | 0.295 | Anesthetic general | 0.271 0.042 DBMET00278 0.289 0.036 DBMET00056 0.278 0.039 DBMET00057 0.278 0.039 DBMET01808 | ||
| 0.357 | 0.097 | 0.357 | Histamine release inhibitor | 0.22 0.18 DBMET00278 0.213 0.187 DBMET00056 0.341 0.104 DBMET00057 0.341 0.104 DBMET01808 | ||
| 0.29 | 0.034 | 0.32 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 DBMET00278 0.32 0.028 DBMET00056 0.239 0.057 DBMET00057 0.239 0.057 DBMET01808 | DBMET00056 | |
| 0.297 | 0.067 | 0.472 | Aldehyde oxidase inhibitor | 0.306 0.065 DBMET00278 0.472 0.037 DBMET00056 0.402 0.047 DBMET00057 0.402 0.047 DBMET01808 | DBMET00056 | |
| 0.272 | 0.049 | 0.323 | Tyrosine 3 hydroxylase inhibitor | 0.299 0.033 DBMET00278 0.269 0.052 DBMET00056 0.323 0.023 DBMET00057 0.323 0.023 DBMET01808 | DBMET01808 | |
| 0.253 | 0.032 | 0.253 | Lipocortins synthesis antagonist | 0.145 0.113 DBMET00278 0.161 0.091 DBMET00056 0.222 0.044 DBMET00057 0.222 0.044 DBMET01808 | ||
| 0.243 | 0.024 | 0.412 | Interleukin 6 antagonist | 0.266 0.02 DBMET00278 0.412 0.007 DBMET00056 0.2 0.04 DBMET00057 0.2 0.04 DBMET01808 | DBMET00056 | |
| 0.244 | 0.028 | 0.244 | Histone acetyltransferase inhibitor | 0.162 0.123 DBMET00056 | ||
| 0.228 | 0.021 | 0.228 | Cell wall synthesis inhibitor | 0.131 0.085 DBMET00056 0.161 0.056 DBMET00057 0.161 0.056 DBMET01808 | ||
| 0.204 | 0.013 | 0.27 | DNA directed RNA polymerase inhibitor | 0.087 0.074 DBMET00278 0.27 0.008 DBMET00056 | DBMET00056 | |
| 0.27 | 0.08 | 0.281 | 5 Hydroxytryptamine release stimulant | 0.281 0.076 DBMET00278 0.238 0.095 DBMET00056 0.251 0.089 DBMET00057 0.251 0.089 DBMET01808 | DBMET00278 | |
| 0.202 | 0.018 | 0.333 | Nav1.6 sodium channel blocker | 0.333 0.005 DBMET00056 | DBMET00056 | |
| 0.342 | 0.16 | 0.389 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.34 0.163 DBMET00278 0.389 0.11 DBMET00056 | DBMET00056 | |
| 0.241 | 0.062 | 0.241 | Psychostimulant | 0.138 0.127 DBMET00056 0.161 0.107 DBMET00057 0.161 0.107 DBMET01808 | ||
| 0.2 | 0.022 | 0.2 | Ferrochelatase inhibitor | 0.178 0.028 DBMET00278 0.199 0.023 DBMET00056 0.123 0.051 DBMET00057 0.123 0.051 DBMET01808 | ||
| 0.254 | 0.077 | 0.259 | 5 Hydroxytryptamine uptake stimulant | 0.259 0.072 DBMET00278 0.231 0.103 DBMET00056 0.251 0.079 DBMET00057 0.251 0.079 DBMET01808 | DBMET00278 | |
| 0.196 | 0.026 | 0.303 | Nav1.3 sodium channel blocker | 0.303 0.009 DBMET00056 | DBMET00056 | |
| 0.2 | 0.034 | 0.375 | Nav1.2 sodium channel blocker | 0.375 0.008 DBMET00056 | DBMET00056 | |
| 0.163 | 0.005 | 0.163 | Kinesin antagonist | 0.056 0.015 DBMET00278 0.082 0.01 DBMET00056 0.142 0.005 DBMET00057 0.142 0.005 DBMET01808 | ||
| 0.163 | 0.005 | 0.163 | Kinesin-like protein 1 inhibitor | 0.056 0.015 DBMET00278 0.082 0.01 DBMET00056 0.142 0.005 DBMET00057 0.142 0.005 DBMET01808 | ||
| 0.19 | 0.035 | 0.193 | GABA C receptor rho-2 antagonist | 0.19 0.035 DBMET00278 0.193 0.033 DBMET00056 0.187 0.037 DBMET00057 0.187 0.037 DBMET01808 | DBMET00056 | |
| 0.129 | 0.007 | 0.129 | Polo-like kinase-2 inhibitor | 0.095 0.03 DBMET00278 0.084 0.04 DBMET00056 0.118 0.011 DBMET00057 0.118 0.011 DBMET01808 | ||
| 0.124 | 0.004 | 0.124 | Liver X receptor beta agonist | 0.05 0.01 DBMET00056 0.031 0.026 DBMET00057 0.031 0.026 DBMET01808 | ||
| 0.223 | 0.105 | 0.223 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.247 | 0.129 | 0.247 | Vasodilator, peripheral | 0.205 0.17 DBMET00057 0.205 0.17 DBMET01808 | ||
| 0.117 | 0.005 | 0.117 | Liver X receptor alpha agonist | 0.058 0.014 DBMET00056 0.049 0.02 DBMET00057 0.049 0.02 DBMET01808 | ||
| 0.148 | 0.038 | 0.148 | Alpha adrenoreceptor antagonist | |||
| 0.119 | 0.01 | 0.119 | Secretase beta inhibitor | 0.106 0.015 DBMET00278 0.102 0.017 DBMET00056 0.112 0.013 DBMET00057 0.112 0.013 DBMET01808 | ||
| 0.235 | 0.136 | 0.292 | Cholesterol antagonist | 0.247 0.128 DBMET00278 0.292 0.097 DBMET00057 0.292 0.097 DBMET01808 | DBMET01808 | |
| 0.148 | 0.051 | 0.148 | Heat shock protein 70 antagonist | 0.142 0.068 DBMET00057 0.142 0.068 DBMET01808 | ||
| 0.217 | 0.123 | 0.217 | Gastrin inhibitor | 0.183 0.174 DBMET00278 0.19 0.164 DBMET00056 | ||
| 0.136 | 0.044 | 0.136 | 5 Hydroxytryptamine 3A agonist | 0.122 0.054 DBMET00056 0.11 0.065 DBMET00057 0.11 0.065 DBMET01808 | ||
| 0.123 | 0.033 | 0.413 | Alcohol dehydrogenase inhibitor | 0.116 0.038 DBMET00278 0.413 0.004 DBMET00056 0.106 0.046 DBMET00057 0.106 0.046 DBMET01808 | DBMET00056 | |
| 0.1 | 0.01 | 0.1 | Phosphodiesterase 1A inhibitor | 0.073 0.022 DBMET00056 0.059 0.043 DBMET00057 0.059 0.043 DBMET01808 | ||
| 0.114 | 0.024 | 0.126 | HIV-1 reverse transcriptase inhibitor | 0.089 0.037 DBMET00278 0.126 0.02 DBMET00056 | DBMET00056 | |
| 0.124 | 0.035 | 0.124 | Alpha 1 adrenoreceptor antagonist | |||
| 0.203 | 0.119 | 0.242 | DNA synthesis inhibitor | 0.229 0.084 DBMET00278 0.242 0.072 DBMET00056 0.186 0.144 DBMET00057 0.186 0.144 DBMET01808 | DBMET00056 | |
| 0.119 | 0.037 | 0.119 | Electrolyte absorption antagonist | 0.098 0.061 DBMET00278 0.098 0.061 DBMET00056 | ||
| 0.226 | 0.148 | 0.226 | Antithrombotic | 0.193 0.186 DBMET00056 | ||
| 0.082 | 0.005 | 0.088 | Pregnane X receptor antagonist | 0.088 0.005 DBMET00278 0.083 0.005 DBMET00056 0.07 0.014 DBMET00057 0.07 0.014 DBMET01808 | DBMET00278 | |
| 0.109 | 0.033 | 0.109 | Alpha 1a adrenoreceptor antagonist | |||
| 0.126 | 0.054 | 0.246 | Cystathionine beta-synthase inhibitor | 0.118 0.059 DBMET00278 0.246 0.016 DBMET00057 0.246 0.016 DBMET01808 | DBMET01808 | |
| 0.187 | 0.118 | 0.261 | Peptidyltransferase inhibitor | 0.176 0.135 DBMET00278 0.261 0.043 DBMET00056 0.198 0.102 DBMET00057 0.198 0.102 DBMET01808 | DBMET00056 | |
| 0.226 | 0.157 | 0.226 | Vasodilator, coronary | 0.192 0.19 DBMET00057 0.192 0.19 DBMET01808 | ||
| 0.084 | 0.016 | 0.118 | MDM2 inhibitor | 0.075 0.028 DBMET00278 0.118 0.004 DBMET00056 0.066 0.05 DBMET00057 0.066 0.05 DBMET01808 | DBMET00056 | |
| 0.108 | 0.039 | 0.108 | Phosphodiesterase 6D inhibitor | 0.092 0.069 DBMET00057 0.092 0.069 DBMET01808 | ||
| 0.106 | 0.038 | 0.106 | Phosphodiesterase I inhibitor | 0.08 0.077 DBMET00278 0.087 0.064 DBMET00056 0.106 0.037 DBMET00057 0.106 0.037 DBMET01808 | ||
| 0.087 | 0.02 | 0.094 | Glutamate (mGluR7) antagonist | 0.082 0.025 DBMET00278 0.067 0.048 DBMET00056 0.094 0.014 DBMET00057 0.094 0.014 DBMET01808 | DBMET01808 | |
| 0.169 | 0.105 | 0.169 | MAP kinase kinase 2 inhibitor | |||
| 0.075 | 0.012 | 0.099 | Nicotinic acid receptor 1 agonist | 0.037 0.033 DBMET00278 0.099 0.008 DBMET00056 0.038 0.031 DBMET00057 0.038 0.031 DBMET01808 | DBMET00056 | |
| 0.279 | 0.218 | 0.336 | Caspase 9 stimulant | 0.336 0.158 DBMET00278 0.293 0.201 DBMET00056 0.307 0.186 DBMET00057 0.307 0.186 DBMET01808 | DBMET00278 | |
| 0.082 | 0.023 | 0.097 | Androgen agonist | 0.075 0.027 DBMET00278 0.097 0.016 DBMET00056 0.072 0.029 DBMET00057 0.072 0.029 DBMET01808 | DBMET00056 | |
| 0.087 | 0.029 | 0.087 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.114 | 0.059 | 0.114 | Acetylcholine release stimulant | |||
| 0.062 | 0.007 | 0.062 | Phosphodiesterase 6C inhibitor | 0.052 0.017 DBMET00057 0.052 0.017 DBMET01808 | ||
| 0.105 | 0.055 | 0.128 | GABA C receptor rho-1 antagonist | 0.128 0.034 DBMET00278 0.121 0.039 DBMET00056 0.096 0.068 DBMET00057 0.096 0.068 DBMET01808 | DBMET00278 | |
| 0.165 | 0.117 | 0.194 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.168 0.112 DBMET00278 0.194 0.078 DBMET00057 0.194 0.078 DBMET01808 | DBMET01808 | |
| 0.081 | 0.033 | 0.081 | Acetylcholine M5 receptor agonist | 0.069 0.044 DBMET00056 | ||
| 0.136 | 0.089 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.153 0.035 DBMET00278 0.137 0.085 DBMET00056 0.144 0.061 DBMET00057 0.144 0.061 DBMET01808 | DBMET00278 | |
| 0.073 | 0.028 | 0.073 | Phosphodiesterase 1B inhibitor | 0.058 0.044 DBMET00278 0.056 0.048 DBMET00056 0.071 0.03 DBMET00057 0.071 0.03 DBMET01808 | ||
| 0.099 | 0.056 | 0.099 | Antiadrenergic | |||
| 0.099 | 0.057 | 0.12 | Prolactin inhibitor | 0.084 0.075 DBMET00278 0.12 0.038 DBMET00057 0.12 0.038 DBMET01808 | DBMET01808 | |
| 0.07 | 0.029 | 0.074 | Phosphodiesterase 1C inhibitor | 0.074 0.025 DBMET00278 0.065 0.036 DBMET00056 0.072 0.027 DBMET00057 0.072 0.027 DBMET01808 | DBMET00278 | |
| 0.087 | 0.047 | 0.095 | Glycine receptor antagonist | 0.095 0.037 DBMET00278 0.095 0.037 DBMET00056 | DBMET00056 | |
| 0.096 | 0.056 | 0.096 | Adrenaline antagonist | |||
| 0.046 | 0.008 | 0.046 | Phosphodiesterase 6B inhibitor | 0.031 0.021 DBMET00057 0.031 0.021 DBMET01808 | ||
| 0.099 | 0.062 | 0.178 | UDP-glucose 4-epimerase inhibitor | 0.131 0.037 DBMET00278 0.178 0.022 DBMET00056 0.092 0.071 DBMET00057 0.092 0.071 DBMET01808 | DBMET00056 | |
| 0.175 | 0.141 | 0.175 | Spasmolytic | |||
| 0.039 | 0.005 | 0.052 | DNA polymerase III inhibitor | 0.052 0.004 DBMET00278 0.035 0.008 DBMET00056 | DBMET00278 | |
| 0.038 | 0.005 | 0.038 | Acid ceramidase inhibitor | 0.03 0.01 DBMET00056 | ||
| 0.046 | 0.018 | 0.286 | Aggrecanase 1 inhibitor | 0.286 0.003 DBMET00056 | DBMET00056 | |
| 0.048 | 0.02 | 0.058 | Thymidine kinase inhibitor | 0.052 0.018 DBMET00278 0.058 0.014 DBMET00056 | DBMET00056 | |
| 0.044 | 0.017 | 0.045 | Potassium channel Kv1.1 blocker | 0.045 0.017 DBMET00056 | DBMET00056 | |
| 0.086 | 0.062 | 0.086 | Bromodomain-containing protein 2 inhibitor | |||
| 0.03 | 0.007 | 0.03 | Phosphodiesterase 6H inhibitor | 0.023 0.017 DBMET00057 0.023 0.017 DBMET01808 | ||
| 0.03 | 0.007 | 0.03 | Phosphodiesterase 6G inhibitor | 0.023 0.017 DBMET00057 0.023 0.017 DBMET01808 | ||
| 0.046 | 0.024 | 0.048 | Angiotensin AT1 receptor antagonist | 0.048 0.02 DBMET00278 0.039 0.036 DBMET00056 0.044 0.026 DBMET00057 0.044 0.026 DBMET01808 | DBMET00278 | |
| 0.071 | 0.05 | 0.089 | Phospholipase D inhibitor | 0.088 0.024 DBMET00278 0.089 0.023 DBMET00056 | DBMET00056 | |
| 0.225 | 0.205 | 0.225 | Transcription factor inhibitor | |||
| 0.039 | 0.022 | 0.083 | Nicotinic acid receptor agonist | 0.037 0.024 DBMET00278 0.083 0.006 DBMET00056 0.036 0.025 DBMET00057 0.036 0.025 DBMET01808 | DBMET00056 | |
| 0.027 | 0.01 | 0.027 | Phosphodiesterase 6A inhibitor | |||
| 0.058 | 0.041 | 0.058 | Calcium channel T-type blocker | |||
| 0.07 | 0.053 | 0.07 | Alpha 1b adrenoreceptor antagonist | |||
| 0.036 | 0.02 | 0.036 | Purinergic P2Y2 antagonist | |||
| 0.111 | 0.096 | 0.14 | Sodium channel (voltage-gated) blocker | 0.14 0.062 DBMET00056 | DBMET00056 | |
| 0.11 | 0.095 | 0.11 | DNA repair enzyme inhibitor | 0.11 0.097 DBMET00056 | ||
| 0.169 | 0.155 | 0.22 | Nitric-oxide synthase stimulant | 0.22 0.06 DBMET00278 0.215 0.066 DBMET00056 0.194 0.099 DBMET00057 0.194 0.099 DBMET01808 | DBMET00278 | |
| 0.031 | 0.017 | 0.077 | Uridine phosphorylase inhibitor | 0.077 0.004 DBMET00278 0.064 0.005 DBMET00056 | DBMET00278 | |
| 0.027 | 0.016 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.011 DBMET00278 0.032 0.009 DBMET00056 | DBMET00056 | |
| 0.041 | 0.03 | 0.051 | Kainate receptor agonist | 0.048 0.017 DBMET00278 0.051 0.013 DBMET00056 | DBMET00056 | |
| 0.015 | 0.005 | 0.016 | DNA polymerase III polC-type inhibitor | 0.016 0.005 DBMET00056 | DBMET00056 | |
| 0.026 | 0.019 | 0.042 | Thymidine phosphorylase inhibitor | 0.042 0.006 DBMET00278 0.034 0.009 DBMET00056 | DBMET00278 | |
| 0.025 | 0.018 | 0.048 | Calcitonin gene-related peptide antagonist | 0.048 0.011 DBMET00056 | DBMET00056 | |
| 0.046 | 0.039 | 0.046 | Adenosine A2b receptor antagonist | |||
| 0.056 | 0.049 | 0.056 | TRPA1 antagonist | |||
| 0.069 | 0.065 | 0.069 | Phosphodiesterase VI inhibitor | |||
| 0.051 | 0.047 | 0.051 | Adenosine A1 receptor antagonist | |||
| 0.032 | 0.028 | 0.035 | Angiotensin II receptor antagonist | 0.035 0.022 DBMET00278 0.032 0.027 DBMET00057 0.032 0.027 DBMET01808 | DBMET00278 | |
| 0.068 | 0.065 | 0.068 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.122 | 0.12 | 0.139 | Sphingosine 1-phosphate receptor 5 antagonist | 0.139 0.081 DBMET00278 | DBMET00278 | |
| 0.036 | 0.034 | 0.052 | Membrane dipeptidase inhibitor | 0.04 0.026 DBMET00278 0.052 0.014 DBMET00056 | DBMET00056 | |
| 0.015 | 0.014 | 0.016 | Calcitonin gene-related peptide 1 receptor antagonist | 0.016 0.014 DBMET00056 | DBMET00056 | |
| 0.083 | 0.082 | 0.179 | Creatine kinase inhibitor | 0.144 0.027 DBMET00278 0.089 0.073 DBMET00056 0.179 0.014 DBMET00057 0.179 0.014 DBMET01808 | DBMET01808 | |
| 0.082 | 0.083 | 0.104 | Bronchodilator | 0.104 0.059 DBMET00057 0.104 0.059 DBMET01808 | DBMET01808 | |
| 0.092 | 0.092 | 0.169 | GABA C receptor antagonist | 0.169 0.021 DBMET00278 0.117 0.056 DBMET00056 | DBMET00278 | |
| 0.1 | 0.101 | 0.235 | Alpha-N-acetylglucosaminidase inhibitor | 0.235 0.026 DBMET00278 0.154 0.053 DBMET00056 | DBMET00278 | |
| 0.019 | 0.022 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET00278 0.028 0.005 DBMET00056 | DBMET00056 | |
| 0.005 | 0.011 | 0.022 | DNA topoisomerase III inhibitor | 0.022 0.002 DBMET00278 0.015 0.003 DBMET00056 | DBMET00278 | |
| 0.048 | 0.056 | 0.101 | Biliverdin reductase inhibitor | 0.074 0.029 DBMET00278 0.101 0.018 DBMET00056 | DBMET00056 | |
| 0.048 | 0.057 | 0.054 | Fatty acid synthase inhibitor | 0.054 0.044 DBMET00057 0.054 0.044 DBMET01808 | DBMET01808 | |
| 0.021 | 0.032 | 0.051 | Nicotinic acid receptor 2 antagonist | 0.025 0.022 DBMET00278 0.051 0.004 DBMET00056 | DBMET00056 | |
| 0.16 | 0.172 | 0.174 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.124 DBMET00056 | DBMET00056 | |
| 0.014 | 0.027 | 0.096 | Aggrecanase 2 inhibitor | 0.096 0.004 DBMET00056 | DBMET00056 | |
| 0.075 | 0.088 | 0.103 | Estrogen-related receptor beta agonist | 0.087 0.048 DBMET00278 0.103 0.021 DBMET00057 0.103 0.021 DBMET01808 | DBMET01808 | |
| 0.115 | 0.13 | 0.244 | Growth hormone agonist | 0.244 0.045 DBMET00056 | DBMET00056 | |
| 0.075 | 0.091 | 0.153 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET00278 0.153 0.026 DBMET00056 | DBMET00056 | |
| 0.044 | 0.066 | 0.082 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.028 DBMET00278 0.065 0.039 DBMET00056 | DBMET00278 | |
| 0.078 | 0.103 | 0.111 | Anabolic | 0.111 0.048 DBMET00278 0.109 0.051 DBMET00056 0.106 0.054 DBMET00057 0.106 0.054 DBMET01808 | DBMET00278 | |
| 0.026 | 0.054 | 0.043 | ADAM10 endopeptidase inhibitor | 0.043 0.013 DBMET00056 | DBMET00056 | |
| 0.051 | 0.083 | 0.078 | Interferon inducer | 0.078 0.026 DBMET00278 | DBMET00278 | |
| 0.017 | 0.05 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET00278 0.023 0.021 DBMET00056 | DBMET00056 | |
| 0.073 | 0.108 | 0.213 | GABA C receptor agonist | 0.213 0.018 DBMET00278 0.123 0.047 DBMET00056 | DBMET00278 | |
| 0.028 | 0.063 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.033 DBMET00278 | DBMET00278 | |
| 0.039 | 0.076 | 0.082 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.082 0.019 DBMET00278 0.066 0.029 DBMET00056 | DBMET00278 | |
| 0.071 | 0.109 | 0.089 | Phosphodiesterase 7B inhibitor | 0.089 0.071 DBMET00056 | DBMET00056 | |
| 0.068 | 0.108 | 0.103 | NADH dehydrogenase inhibitor | 0.1 0.044 DBMET00278 0.103 0.041 DBMET00056 | DBMET00056 | |
| 0.032 | 0.072 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.033 DBMET00057 0.038 0.033 DBMET01808 | DBMET01808 | |
| 0.038 | 0.078 | 0.056 | NMDA receptor glycine site agonist | 0.056 0.05 DBMET00056 | DBMET00056 | |
| 0.089 | 0.131 | 0.115 | Sodium channel blocker | 0.115 0.09 DBMET00056 | DBMET00056 | |
| 0.035 | 0.077 | 0.073 | Argininosuccinate synthase inhibitor | 0.057 0.04 DBMET00278 0.073 0.028 DBMET00056 | DBMET00056 | |
| 0.058 | 0.101 | 0.092 | Interferon agonist | 0.092 0.036 DBMET00278 | DBMET00278 | |
| 0.182 | 0.227 | 0.383 | Toll-Like receptor 7 agonist | 0.218 0.18 DBMET00056 0.383 0.067 DBMET00057 0.383 0.067 DBMET01808 | DBMET01808 | |
| 0.041 | 0.088 | 0.078 | Dihydroorotate oxidase inhibitor | 0.078 0.012 DBMET00056 | DBMET00056 | |
| 0.178 | 0.231 | 0.38 | Toll-Like receptor agonist | 0.214 0.185 DBMET00056 0.38 0.069 DBMET00057 0.38 0.069 DBMET01808 | DBMET01808 | |
| 0.052 | 0.105 | 0.085 | Glutamate (mGluR6) antagonist | 0.085 0.019 DBMET00278 0.068 0.045 DBMET00056 | DBMET00278 | |
| 0.029 | 0.083 | 0.043 | Adenylate cyclase 1 inhibitor | 0.043 0.036 DBMET00278 | DBMET00278 | |
| 0.177 | 0.232 | 0.211 | Interleukin 2 agonist | 0.211 0.171 DBMET00057 0.211 0.171 DBMET01808 | DBMET01808 | |
| 0.058 | 0.113 | 0.096 | Antineoplastic alkaloid | 0.096 0.05 DBMET00057 0.096 0.05 DBMET01808 | DBMET01808 | |
| 0.076 | 0.132 | 0.122 | Adenylate kinase inhibitor | 0.122 0.042 DBMET00278 0.094 0.079 DBMET00056 | DBMET00278 | |
| 0.023 | 0.081 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.027 DBMET00056 | DBMET00056 | |
| 0.037 | 0.095 | 0.084 | Collagenase 3 inhibitor | 0.084 0.022 DBMET00056 | DBMET00056 | |
| 0.016 | 0.075 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET00278 0.03 0.029 DBMET00056 | DBMET00056 | |
| 0.037 | 0.096 | 0.095 | Phosphofructokinase-1 inhibitor | 0.095 0.034 DBMET00278 0.077 0.043 DBMET00056 | DBMET00278 | |
| 0.052 | 0.115 | 0.07 | Glycine receptor agonist | 0.07 0.055 DBMET00278 | DBMET00278 | |
| 0.079 | 0.143 | 0.106 | Photosensitizer | 0.106 0.077 DBMET00278 | DBMET00278 | |
| 0.051 | 0.116 | 0.091 | Metalloproteinase-9 inhibitor | 0.091 0.037 DBMET00056 | DBMET00056 | |
| 0.022 | 0.089 | 0.044 | Antimetabolite | 0.044 0.036 DBMET00278 | DBMET00278 | |
| 0.02 | 0.089 | 0.045 | Dopamine D5 agonist | 0.045 0.022 DBMET00278 | DBMET00278 | |
| 0.004 | 0.075 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DBMET00278 | DBMET00278 | |
| 0.017 | 0.089 | 0.084 | NMDA receptor subunit 3A antagonist | 0.084 0.011 DBMET00278 0.067 0.015 DBMET00057 0.067 0.015 DBMET01808 | DBMET00278 | |
| 0.033 | 0.106 | 0.436 | Phosphodiesterase III inhibitor | 0.436 0.003 DBMET00278 0.061 0.051 DBMET00056 0.273 0.005 DBMET00057 0.273 0.005 DBMET01808 | DBMET00278 | |
| 0.019 | 0.092 | 0.171 | Macrophage elastase inhibitor | 0.171 0.005 DBMET00056 | DBMET00056 | |
| 0.02 | 0.094 | 0.059 | Glutamate (mGluR3) antagonist | 0.059 0.009 DBMET00278 | DBMET00278 | |
| 0.041 | 0.116 | 0.089 | Glutamate decarboxylase inhibitor | 0.089 0.037 DBMET00278 0.079 0.045 DBMET00057 0.079 0.045 DBMET01808 | DBMET00278 | |
| 0.028 | 0.104 | 0.091 | Alcohol oxidase inhibitor | 0.091 0.021 DBMET00278 0.049 0.047 DBMET00056 0.063 0.033 DBMET00057 0.063 0.033 DBMET01808 | DBMET00278 | |
| 0.046 | 0.125 | 0.071 | Glutamate dehydrogenase inhibitor | 0.071 0.056 DBMET00278 | DBMET00278 | |
| 0.046 | 0.127 | 0.1 | Metalloproteinase-2 inhibitor | 0.1 0.038 DBMET00056 | DBMET00056 | |
| 0.036 | 0.12 | 0.071 | Histidine decarboxylase inhibitor | 0.071 0.05 DBMET00278 0.067 0.054 DBMET00057 0.067 0.054 DBMET01808 | DBMET00278 | |
| 0.063 | 0.147 | 0.08 | D-Ala-D-Ala ligase inhibitor | 0.08 0.068 DBMET00057 0.08 0.068 DBMET01808 | DBMET01808 | |
| 0.035 | 0.119 | 0.127 | Phenylalanine 4-hydroxylase inhibitor | 0.127 0.016 DBMET00278 0.068 0.048 DBMET00057 0.068 0.048 DBMET01808 | DBMET00278 | |
| 0.025 | 0.111 | 0.053 | Acyl-CoA dehydrogenase inhibitor | 0.053 0.039 DBMET00278 | DBMET00278 | |
| 0.009 | 0.095 | 0.031 | Kainate receptor 4 antagonist | 0.031 0.013 DBMET00278 | DBMET00278 | |
| 0.08 | 0.167 | 0.114 | Cytidine deaminase inhibitor | 0.114 0.107 DBMET00278 | DBMET00278 | |
| 0.047 | 0.135 | 0.15 | NMDA receptor antagonist | 0.15 0.024 DBMET00278 0.127 0.032 DBMET00057 0.127 0.032 DBMET01808 | DBMET00278 | |
| 0.085 | 0.174 | 0.118 | Sphingosine 1-phosphate receptor 4 antagonist | 0.118 0.077 DBMET00278 | DBMET00278 | |
| 0.194 | 0.284 | 0.275 | Calcium channel L-type activator | 0.244 0.212 DBMET00056 0.275 0.18 DBMET00057 0.275 0.18 DBMET01808 | DBMET01808 | |
| 0.049 | 0.14 | 0.114 | Aminopeptidase B inhibitor | 0.114 0.056 DBMET00278 | DBMET00278 | |
| 0.113 | 0.206 | 0.199 | Neurotrophic factor enhancer | 0.199 0.078 DBMET00278 0.192 0.084 DBMET00057 0.192 0.084 DBMET01808 | DBMET00278 | |
| 0.009 | 0.103 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 DBMET00278 | DBMET00278 | |
| 0.039 | 0.135 | 0.074 | Aminopeptidase I inhibitor | 0.074 0.049 DBMET00278 | DBMET00278 | |
| 0.035 | 0.132 | 0.116 | Porphobilinogen synthase inhibitor | 0.116 0.029 DBMET00278 0.065 0.061 DBMET00057 0.065 0.061 DBMET01808 | DBMET00278 | |
| 0.013 | 0.112 | 0.042 | Nicotinic acid receptor 2 agonist | 0.042 0.019 DBMET00056 | DBMET00056 | |
| 0.007 | 0.106 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET00056 | DBMET00056 | |
| 0.027 | 0.126 | 0.06 | Matrix metalloproteinase (membrane-type) inhibitor | 0.06 0.033 DBMET00056 | DBMET00056 | |
| 0.03 | 0.131 | 0.075 | Matrix metalloproteinase inhibitor | 0.075 0.04 DBMET00056 | DBMET00056 | |
| 0.051 | 0.154 | 0.236 | HIV-1 integrase (Overall Integration) inhibitor | 0.236 0.006 DBMET00278 0.106 0.049 DBMET00056 | DBMET00278 | |
| 0.055 | 0.158 | 0.097 | Triose-phosphate isomerase inhibitor | 0.097 0.051 DBMET00278 | DBMET00278 | |
| 0.086 | 0.193 | 0.179 | Mannose-6-phosphate isomerase inhibitor | 0.179 0.043 DBMET00278 0.173 0.047 DBMET00057 0.173 0.047 DBMET01808 | DBMET00278 | |
| 0.013 | 0.123 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.023 DBMET00278 | DBMET00278 | |
| 0.093 | 0.205 | 0.133 | Adenylate cyclase stimulant | 0.133 0.096 DBMET00278 | DBMET00278 | |
| 0.057 | 0.171 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | 0.11 0.042 DBMET00278 | DBMET00278 | |
| 0.106 | 0.222 | 0.202 | Succinate dehydrogenase inhibitor | 0.202 0.047 DBMET00278 0.145 0.123 DBMET00056 | DBMET00278 | |
| 0.073 | 0.193 | 0.232 | Peroxidase inhibitor | 0.232 0.051 DBMET00278 0.119 0.1 DBMET00056 0.169 0.069 DBMET00057 0.169 0.069 DBMET01808 | DBMET00278 | |
| 0.025 | 0.145 | 0.058 | Aconitate hydratase inhibitor | 0.058 0.028 DBMET00278 | DBMET00278 | |
| 0.144 | 0.266 | 0.198 | Insulysin inhibitor | 0.198 0.16 DBMET00278 0.188 0.176 DBMET00056 | DBMET00278 | |
| 0.017 | 0.143 | 0.046 | Thymidylate synthase inhibitor | 0.046 0.033 DBMET00278 | DBMET00278 | |
| 0.056 | 0.182 | 0.09 | Granulocyte macrophage colony stimulating factor agonist | 0.09 0.052 DBMET00278 | DBMET00278 | |
| 0.064 | 0.196 | 0.132 | DOPA decarboxylase inhibitor | 0.132 0.033 DBMET00278 0.116 0.05 DBMET00057 0.116 0.05 DBMET01808 | DBMET00278 | |
| 0.018 | 0.153 | 0.059 | NMDA receptor subunit 3B antagonist | 0.059 0.02 DBMET00278 | DBMET00278 | |
| 0.078 | 0.215 | 0.175 | Arachidonic acid antagonist | 0.175 0.059 DBMET00278 0.127 0.116 DBMET00057 0.127 0.116 DBMET01808 | DBMET00278 | |
| 0.018 | 0.155 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.026 DBMET00278 | DBMET00278 | |
| 0.024 | 0.162 | 0.047 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.034 DBMET00278 | DBMET00278 | |
| 0.016 | 0.156 | 0.106 | Aldose reductase inhibitor | 0.106 0.017 DBMET00056 | DBMET00056 | |
| 0.012 | 0.156 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.026 DBMET00278 | DBMET00278 | |
| 0.107 | 0.252 | 0.143 | Neurotensin receptor agonist | 0.14 0.127 DBMET00278 0.143 0.119 DBMET00056 | DBMET00056 | |
| 0.004 | 0.149 | 0.016 | Endothelin B receptor antagonist | 0.016 0.015 DBMET00278 | DBMET00278 | |
| 0.016 | 0.172 | 0.03 | Glutamate (mGluR3) agonist | 0.03 0.028 DBMET00278 | DBMET00278 | |
| 0.024 | 0.18 | 0.051 | Cytokine production stimulant | 0.051 0.026 DBMET00278 | DBMET00278 | |
| 0.041 | 0.198 | 0.078 | Keratolytic | 0.078 0.051 DBMET00056 | DBMET00056 | |
| 0.084 | 0.246 | 0.244 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.244 0.08 DBMET00278 | DBMET00278 | |
| 0.088 | 0.254 | 0.138 | CF transmembrane conductance regulator agonist | 0.138 0.1 DBMET00278 | DBMET00278 | |
| 0.178 | 0.348 | 0.284 | 5 Hydroxytryptamine release inhibitor | 0.284 0.183 DBMET00278 0.266 0.207 DBMET00056 | DBMET00278 | |
| 0.05 | 0.224 | 0.191 | Interleukin 5 antagonist | 0.088 0.057 DBMET00056 0.191 0.006 DBMET00057 0.191 0.006 DBMET01808 | DBMET01808 | |
| 0.008 | 0.187 | 0.087 | Dopamine D5 antagonist | 0.087 0.011 DBMET00057 0.087 0.011 DBMET01808 | DBMET01808 | |
| 0.027 | 0.225 | 0.118 | Purinergic P2X1 antagonist | 0.118 0.012 DBMET00278 | DBMET00278 | |
| 0.01 | 0.211 | 0.454 | Phosphodiesterase 3B inhibitor | 0.454 0.002 DBMET00278 0.335 0.004 DBMET00057 0.335 0.004 DBMET01808 | DBMET00278 | |
| 0.031 | 0.237 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.054 DBMET00278 | DBMET00278 | |
| 0.087 | 0.305 | 0.146 | Phospholipase C inhibitor | 0.146 0.115 DBMET00278 | DBMET00278 | |
| 0.067 | 0.295 | 0.195 | Immunostimulant | 0.195 0.123 DBMET00278 | DBMET00278 | |
| 0.027 | 0.256 | 0.152 | Phosphodiesterase 3A inhibitor | 0.152 0.015 DBMET00278 0.072 0.069 DBMET00057 0.072 0.069 DBMET01808 | DBMET00278 | |
| 0.112 | 0.353 | 0.252 | Sodium/bile acid cotransporter inhibitor | 0.252 0.126 DBMET00057 0.252 0.126 DBMET01808 | DBMET01808 | |
| 0.037 | 0.281 | 0.071 | Estrogen receptor alpha antagonist | 0.071 0.065 DBMET00278 0.071 0.065 DBMET00057 0.071 0.065 DBMET01808 | DBMET01808 | |
| 0.068 | 0.319 | 0.126 | Melanin inhibitor | 0.126 0.121 DBMET00278 | DBMET00278 | |
| 0.038 | 0.291 | 0.13 | Xanthine oxidase inhibitor | 0.13 0.043 DBMET00278 | DBMET00278 | |
| 0.04 | 0.305 | 0.134 | Beta amyloid protein antagonist | 0.134 0.053 DBMET00057 0.134 0.053 DBMET01808 | DBMET01808 | |
| 0.001 | 0.303 | 0.007 | DNA polymerase III subunit alpha inhibitor | 0.007 0.005 DBMET00278 | DBMET00278 | |
| 0.023 | 0.333 | 0.102 | Glucosylceramidase inhibitor | 0.102 0.008 DBMET00278 | DBMET00278 | |
| 0.046 | 0.359 | 0.355 | Interleukin antagonist | 0.355 0.038 DBMET00057 0.355 0.038 DBMET01808 | DBMET01808 | |
| 0.011 | 0.345 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.022 DBMET00057 0.033 0.022 DBMET01808 | DBMET01808 | |
| 0.032 | 0.369 | 0.187 | Heme oxygenase stimulant | 0.187 0.002 DBMET00278 0.088 0.01 DBMET00057 0.088 0.01 DBMET01808 | DBMET00278 | |
| 0.009 | 0.356 | 0.05 | Xanthine dehydrogenase inhibitor | 0.05 0.046 DBMET00278 | DBMET00278 | |
| 0.044 | 0.395 | 0.654 | Interleukin 4 antagonist | 0.175 0.032 DBMET00278 0.654 0.004 DBMET00057 0.654 0.004 DBMET01808 | DBMET01808 | |
| 0.034 | 0.409 | 0.135 | Estrogen antagonist | 0.106 0.084 DBMET00278 0.135 0.032 DBMET00057 0.135 0.032 DBMET01808 | DBMET01808 | |
| 0.016 | 0.428 | 0.147 | Glutamate receptor antagonist | 0.147 0.053 DBMET00278 | DBMET00278 | |
| 0.022 | 0.444 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.032 DBMET00057 0.12 0.032 DBMET01808 | DBMET01808 | |
| 0.006 | 0.442 | 0.091 | Phosphodiesterase 2A inhibitor | 0.091 0.01 DBMET00278 0.063 0.022 DBMET00057 0.063 0.022 DBMET01808 | DBMET00278 | |
| 0.039 | 0.483 | 0.298 | Tumour necrosis factor alpha release inhibitor | 0.298 0.054 DBMET00056 | DBMET00056 | |
| 0.004 | 0.452 | 0.041 | Purinergic P2Y12 antagonist | 0.041 0.008 DBMET00278 | DBMET00278 | |
| 0.005 | 0.455 | 0.1 | Phosphodiesterase II inhibitor | 0.1 0.011 DBMET00278 0.071 0.023 DBMET00057 0.071 0.023 DBMET01808 | DBMET00278 | |
| 0.048 | 0.508 | 0.214 | 15-Lipoxygenase inhibitor | 0.214 0.198 DBMET00278 | DBMET00278 | |
| 0.041 | 0.573 | 0.762 | Antiobesity | 0.762 0.007 DBMET00278 0.674 0.013 DBMET00057 0.674 0.013 DBMET01808 | DBMET00278 | |
| 0.008 | 0.656 | 0.167 | M17 leucyl aminopeptidase inhibitor | 0.167 0.046 DBMET00278 | DBMET00278 | |
| 0.009 | 0.71 | 0.118 | Uric acid excretion stimulant | 0.118 0.039 DBMET00278 | DBMET00278 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |